Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences

P Anagnostis, BC Tarlatzis, RP Kauffman - Metabolism, 2018 - Elsevier
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women during
their reproductive ages, associated with a plethora of cardiometabolic consequences, with …

Epidemiology, diagnosis, and management of polycystic ovary syndrome

SM Sirmans, KA Pate - Clinical epidemiology, 2013 - Taylor & Francis
Polycystic ovary syndrome (PCOS) is a common heterogeneous endocrine disorder
characterized by irregular menses, hyperandrogenism, and polycystic ovaries. The …

Polycystic ovary syndrome

DA Ehrmann - New England Journal of Medicine, 2005 - Mass Medical Soc
The polycystic ovary syndrome is one of the most common hormonal disorders affecting
women. It has multiple components—reproductive, metabolic, and cardiovascular—with …

Cardiometabolic aspects of the polycystic ovary syndrome

HS Randeva, BK Tan, MO Weickert, K Lois… - Endocrine …, 2012 - academic.oup.com
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder amongst women
of reproductive age and is associated with various metabolic perturbations, in addition to …

[HTML][HTML] Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis

RA Wild, M Rizzo, S Clifton, E Carmina - Fertility and sterility, 2011 - Elsevier
OBJECTIVE: To quantify the magnitude and pattern of low-density lipoprotein (LDL)
cholesterol and nonhigh-density lipoprotein (HDL) cholesterol levels in women with …

[HTML][HTML] Day–night pattern of sudden death in obstructive sleep apnea

AS Gami, DE Howard, EJ Olson… - New England Journal of …, 2005 - Mass Medical Soc
Background The risk of sudden death from cardiac causes in the general population peaks
from 6 am to noon and has a nadir from midnight to 6 am Obstructive sleep apnea is highly …

Polycystic ovary syndrome and cardiovascular disease: a premature association?

RS Legro - Endocrine reviews, 2003 - academic.oup.com
Women with polycystic ovary syndrome (PCOS) are often assumed, a priori, to be at
increased risk for cardiovascular disease (CVD), given the high prevalence of the metabolic …

Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome

KA Toulis, DG Goulis, G Mintziori… - Human reproduction …, 2011 - academic.oup.com
BACKGROUND The relation between polycystic ovary syndrome (PCOS) and
cardiovascular disease (CVD) remains unclear. In an attempt to provide high-quality …

Adrenarche–physiology, biochemistry and human disease

RJ Auchus, WE Rainey - Clinical endocrinology, 2004 - Wiley Online Library
Adrenarche refers to the onset of dehydroepiandrosterone (DHEA) and DHEA‐sulphate
(DHEA‐S) production from the adrenal zona reticularis that can be detected at around 6 …

Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome

N Cinar, MC Kizilarslanoglu, A Harmanci… - Human …, 2011 - academic.oup.com
BACKGROUND Polycystic ovary syndrome (PCOS) is associated with psychological and
metabolic disturbances. The aim of this study was to determine whether depression, anxiety …